EcoDrugPlus

Bruton Tyrosine Kinase

Ensembl ID : ENSPLAG00000004069
Gene Symbol: BTK
3 Cross references
204 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSPLAG00000016413
Gene Symbol: CCR9
1 Cross references
193 Possible Orthologues:

C-X-C Motif Chemokine Receptor 2

Ensembl ID : ENSPLAG00000009009
Gene Symbol: CXCR2
3 Cross references
275 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSPLAG00000020681
Gene Symbol: CXCR4
4 Cross references
201 Possible Orthologues:

C-Reactive Protein-Like

Ensembl ID : ENSPLAG00000009702
Gene Symbol: LOC106945730
2 Cross references
391 Possible Orthologues:

C-Reactive Protein-Like

Ensembl ID : ENSPLAG00000017671
Gene Symbol: LOC106941563
2 Cross references
377 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSPLAG00000016694
Gene Symbol: CFTR
3 Cross references
214 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSPLAG00000021412
Gene Symbol: DNMT1
3 Cross references
210 Possible Orthologues:

Dna Topoisomerase 1-Like

Ensembl ID : ENSPLAG00000019552
Gene Symbol: LOC106964922
3 Cross references
207 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSPLAG00000021950
Gene Symbol: TOP2A
3 Cross references
209 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSPLAG00000018367
Gene Symbol: TOP2B
3 Cross references
207 Possible Orthologues:

E-Selectin-Like

Ensembl ID : ENSPLAG00000000370
Gene Symbol: LOC106963975
2 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).